MSN US arm completes maiden USFDA audit with zero observations
Hyderabad: MSN Pharmaceuticals Inc. (MSNPI), a wholly owned subsidiary of Hyderabad-based MSN Group of companies, based out of Piscataway, New Jersey, USA completed its maiden USFDA audit with zero observations. The finished dosages facility was established to enhance MSN Group’s product portfolio as well as contract development & manufacturing services, in the US and several […]
Hyderabad: MSN Pharmaceuticals Inc. (MSNPI), a wholly owned subsidiary of Hyderabad-based MSN Group of companies, based out of Piscataway, New Jersey, USA completed its maiden USFDA audit with zero observations.
The finished dosages facility was established to enhance MSN Group’s product portfolio as well as contract development & manufacturing services, in the US and several other key regulatory markets.
“This is a major accomplishment for us. It augments the core strategy of establishing ourselves as a preferred contract development and manufacturing service provider globally, offering end-to-end drug manufacturing services,” MSN said.
Backed by novel technologies and R&D expertise, MSNPI is equipped to deliver pharmaceutical products in general and Drug Enforcement Agency (DEA) controlled categories.
In addition, the production and backward integration capabilities help in catering to large-scale commercial volumes of US-made pharmaceutical products.
Now you can get handpicked stories from Telangana Today on Telegram everyday.
Click the link to subscribe. Click to follow Telangana Today Facebook page and Twitter .
